Value-Based Pricing in the UK and Potential Patient Access Hurdles to Innovative Drugs

Abstract

essary duplication of effort must be eliminated. However, doing so is difficult due to the current culture of data protectionism and a lack of suitable software that enables convenient and useful sharing of the intermediate results. ApproAch: Building on our previously published reviews of software for systematic review and trial analytics, the talk identifies the technical and cultural challenges to be met. We propose that a web-based solution enabling the global research community to contribute their intermediate results in exchange for access to the data contributed by others could rapidly gain momentum. Such a system would challenge data protectionism by greatly reducing the level of investment required for data acquisition. conclusion: A disruptive web-based system enabling a massively collaborative approach to systematic reviewing can make data protectionism obsolete and eliminate much of the effort required for future systematic reviews.